Moneycontrol
Get App
SENSEX NIFTY
you are here:

AstraZeneca Pharma Ltd.

BSE: 506820 | NSE: ASTRAZEN |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE203A01020 | SECTOR: Pharmaceuticals

Success
Alert
Please select a Day.
Info

BSE Live

Jan 21, 16:00
2566.00 77.55 (3.12%)
Volume
AVERAGE VOLUME
5-Day
644
10-Day
742
30-Day
1,272
407
  • Prev. Close

    2488.45

  • Open Price

    2511.65

2508.80

Today’s L/H

2570.00
1400.10

52 Wk L/H

2927.25
1990.80

L/U Price Band

2986.10
  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

  •  VWAP

    2526.81
     Beta
    0.75
  • Market Depth (21 Jan 2020)

    BUYSELL
    QTY PRICE PRICE QTY
    6 2566.00 2570.00 2
    6 2562.60 2574.35 49
    49 2561.20 2575.00 1
    99 2551.55 2578.60 99
    50 2551.00 2579.00 10
    0 Total Total 0
     Market Depth
    BUY 0
    SELL 0
    0%
    0%

NSE Live

Jan 21, 15:57
2548.45 57.25 (2.30%)
Volume
AVERAGE VOLUME
5-Day
15,372
10-Day
18,276
30-Day
20,161
11,564
  • Prev. Close

    2491.20

  • Open Price

    2500.00

2485.40

Today’s L/H

2570.00
1570.00

52 Wk L/H

2931.85
1993.00

L/U Price Band

2989.40
  • Bid Price (Qty.)

    2548.45 (755)

  • Offer Price (Qty.)

    0.00 (0)

  •  VWAP

    2529.94
     Beta
    0.76
  • DELIVERY AVERAGES
    3-Day
    60.72%
    5-Day
    61.63%
    8-Day
    57.30%
    Deliverables
  • SMA VOLUME
    30
    2650.81
    50
    2661.43
    150
    2266.47
    200
    2229.08
    SMA
    2650.81

Charts

  • Open : -
  • High : -
  • Low -
  • Close: -
  • Volume -

TECHNICAL ANALYSIS

TECHNICAL RATING
bearish
Moving Averages Bullish
Technical Indicators Bearish
Moving Averages Crossovers Bearish
Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 2530.33 2569.47 2591.13 2508.67 2469.53 2447.87 2408.73
Fibonacci 2531.89 2546.24 2569.47 2508.67 2485.44 2471.09 2447.87
Camarilla 2496.77 2502.35 2507.92 2508.67 2485.63 2480.05 2474.48

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

SIMPLE MOVING AVERAGES
Days NSE
5 2528.60
10 2539.94
20 2583.20
50 2661.43
100 2440.58
200 2229.08
Pivot levels

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 2577.30 2627.65 2665.30 2539.65 2489.30 2451.65 2401.30
Fibonacci 2573.27 2594.03 2627.65 2539.65 2506.03 2485.27 2451.65
Camarilla 2535.02 2543.08 2551.15 2539.65 2518.88 2510.82 2502.75

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

SIMPLE MOVING AVERAGES
Pivot levels

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 2835.63 3054.67 3177.48 2712.82 2493.78 2370.97 2151.93
Fibonacci 2843.40 2924.08 3054.67 2712.82 2582.23 2501.55 2370.97
Camarilla 2647.94 2679.27 2710.61 2712.82 2585.26 2553.93 2522.59

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

SIMPLE MOVING AVERAGES
Pivot levels

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

Valuation

    • Market Cap (Rs Cr.)
      6,415.00
    • P/E
      85.12
    • Book Value (Rs)
      120.32
    • Dividend (%)
      0.00
    • Market Lot
      1
    • Industry P/E
      31.09
    • EPS (TTM)
      29.94
    • P/C
      70.97
    • Price/Book
      21.33
    • Dividend Yield.(%)
      -
    • Face Value (RS)
      2.00
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      60.72
      5-Day
      61.63
      8-Day
      57.30
      76.09

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

    • Market Cap (Rs Cr.)
      6,415.00
    • P/E
      -
    • Book Value (Rs)
      -
    • Dividend (%)
      0.00
    • Market Lot
      1
    • Industry P/E
      31.09
    • EPS (TTM)
      -
    • P/C
      -
    • Price/Book
      -
    • Dividend Yield.(%)
      -
    • Face Value (RS)
      -
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      60.72
      5-Day
      61.63
      8-Day
      57.30
      76.09

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

Forum

Community Sentiments

  • 20% BUY
  • 80% SELL
  • 0% HOLD
80%
of moneycontrol users recommend selling AstraZeneca

What's your call on AstraZeneca today?

Read 3 investor views

BUY SELL HOLD

Action in AstraZeneca Pharma Ltd.

  • Technicals

    AstraZeneca closes above 50-Day,150-Day Moving Average today.

    Sep 05

  • Technicals

    AstraZeneca closes above 50-Day,150-Day Moving Average today.

    Sep 05

  • Technicals

    AstraZeneca closes above 30-Day,200-Day Moving Average today.

    Aug 29

  • Technicals

    AstraZeneca closes below 30-Day,200-Day Moving Average today.

    Aug 28

  • Technicals

    AstraZeneca closes above 200-Day Moving Average of 1839.45 today.

    Aug 27

  • Dividend

    AstraZeneca Dividend, Interim Dividend 50.00%, Announcement date: Aug 07, 2019, Record date: Aug 21, 2019, Ex-Div: Aug 20, 2019

    Aug 19, 11:00

  • Technicals

    AstraZeneca closes above 50-Day,150-Day Moving Average today.

    Aug 07

  • AGM/EGM

    AstraZeneca AGM on Aug 07, 2019, Announcement date: Jul 11, 2019

    Aug 06, 11:00

  • Technicals

    AstraZeneca closes below 150-Day Moving Average of 1920.04 today.

    Aug 01

  • Technicals

    AstraZeneca closes above its 30-Day,50-Day,150-Day Moving Average today.

    Jul 30

  • Technicals

    AstraZeneca closes above its 30-Day,50-Day,150-Day Moving Average today.

    Jul 30

  • Technicals

    AstraZeneca closes above 30-Day Moving Average of 1970.57 today.

    Jul 09

  • Technicals

    AstraZeneca closes above 50-Day Moving Average of 2101.96 today.

    Jun 28

  • Technicals

    AstraZeneca closes above 30-Day Moving Average of 2008.00 today.

    Jun 26

  • Technicals

    AstraZeneca closes above 30-Day Moving Average of 2009.21 today.

    Jun 26

  • Technicals

    AstraZeneca closes above 30-Day Moving Average of 2217.19 today.

    May 23

  • Technicals

    AstraZeneca closes above 30-Day Moving Average of 2217.81 today.

    May 23

  • Technicals

    AstraZeneca closes above 30-Day Moving Average of 2165.24 today.

    May 15

  • Technicals

    AstraZeneca closes above 30-Day Moving Average of 2156.76 today.

    May 14

  • Technicals

    AstraZeneca closes above 30-Day Moving Average of 1978.03 today.

    Apr 10

Pre-Opening Session Prices9:00 am - 9:15 am

BSE - No shares traded

NSE

Jan 21, 09:15
2500.00 8.80 (0.35%)
High 2500.00
Low 2493.00
Prev. Close 2491.20

Financials

Income Statement

  Sep 2019 Jun 2019 Mar 2019 Dec 2018 Sep 2018
Net Sales 208.48 204.56 190.30 215.19 161.36
Other Income 3.16 2.99 6.01 3.50 3.35
PBDIT 33.57 35.57 6.36 40.88 14.77
Net Profit 14.42 21.52 9.82 29.09 9.13

Balance Sheet

Standalone Mar 2019 Mar 2018
Total Share Capital 5.00 5.00
Networth 300.80 246.93
Total Debt 0.00 0.00
Net Block 74.83 75.46
Investments 0.00 0.00
Total Assets 300.80 246.93

Historical Prices

On
Current Price %Gain / Loss
Open Price 1609.15 2511.65
56.09
High Price 1630.50 2570.00
57.62
Low Price 1592.65 2508.80
57.52
Close Price 1606.30 2488.45
54.92
Volume 784 407
-48.09
On
Current Price %Gain / Loss
Open Price 1607.60 2500.00
55.51
High Price 1630.00 2570.00
57.67
Low Price 1600.05 2485.40
55.33
Close Price 1616.25 2491.20
54.13
Volume 5,161 11,564
124.07
Click Here to view the Open, High, Low, Close, Volume and Historic data for
Index Price Change %Chg
NIFTY 50 12169.90 -54.60 -0.45
SENSEX 41323.81 -205.10 -0.49
NIFTY BANK 30947.50 -133.15 -0.43
NIFTY IT 16175.20 -31.95 -0.20
S&P BSE Smallcap 14651.76 0.59 0.00
Index Price Change %Chg
Nasdaq (Jan 21) 9,366.25 -22.69 -0.24
DAX (Jan 21) 13,543.18 -5.76 -0.04
CAC (Jan 21) 6,037.86 -40.68 -0.67
FTSE (Jan 21) 7,605.85 -45.59 -0.60
SGX Nifty (Jan 21) 12,200.50 9.50 0.08

CORPORATE ACTION

Date Agenda
Aug 07, 2019 Quarterly Results & Interim Dividend
May 24, 2019 Audited Results
Feb 06, 2019 Quarterly Results
Type Dividend% Ex-Dividend date
Interim 50.00 Aug 20, 2019
Final 175.00 Jul 09, 2012
Final 500.00 Jul 07, 2011
Final 500.00 May 06, 2010
Final 750.00 Apr 29, 2009
Ratio Announcement Date Ex-Bonus
1:1 Oct 04, 1995 Nov 13, 1995
Old FV New FV Ex-Split
10 2 Jun 15, 2006
Ratio Premium Ex-Bonus
No Rights Information is available for AstraZeneca Pharma
Date Agenda
Aug 07, 2019 -
Sep 10, 2018 -
Sep 13, 2017 -
Aug 11, 2016 -
Sep 02, 2015 -

Dividend Summary

The company has a good dividend track report and has consistently declared dividends for the last 5 years.

SHARE HOLDING PATTERN & MUTUAL FUND HOLDING

Share Holding Pattern in (%)

Standalone June 2019 March 2019 December 2018 September 2018
Promoters 75 75 75 75
Pledged 0 0 0 0
FII/FPI 2.17 1.69 0.59 0.49
Total DII 8.05 8.32 9.25 9.82
Fin.Insts 0.05 0.03 0.05 0.06
Insurance Co 0 0 0 0
MF 3.66 4.23 5.32 5.44
Others DIIs 4.34 4.06 3.88 4.32
Others 14.78 14.99 15.17 14.69
Total 100 100 100.01 100

Mutual Funds Holding

Data not available

PEERS COMPARISON

Company Name Last Price % Change 52 Wk High 52 Wk Low Market Cap Sales Qtr Net Profit Qtr
AstraZeneca 2566.00 3.12 2927.25 1400.10 6415 728.29 54.44
Sun Pharma 447.35 -0.50 484.10 350.40 107334.25 10,303.21 816.60
Dr Reddys Labs 3048.40 -0.31 3080.70 2065.30 50653.17 10,625.50 1,277.30
Divis Labs 1867.15 -1.42 1925.25 1460.55 49566.97 4,879.66 1,332.65
Cipla 473.25 -1.44 585.50 389.55 38154.72 12,374.01 1,888.41

COMPANY OVERVIEW

Astrazeneca Pharma India Ltd (AZPIL) is engaged in the business of manufacturing and marketing pharmaceutical products in healthcare segments namely gastrointestinal, cardiovascular, cancer, respiratory, neurosciences and infection. The company manufactures a wide variety of products under each of it`s segment which include the following Cardiovascular- Under this segment company manufactures and markets products namely Betaloc, Seloken XL, Imdur, Ramace and Plendil and many more,Respiratory-Company develops drugs such as Rhinocort, Mits Linctus, Bricarex, Bricanyl, etc.,Maternal Healthcare- Under this segment, company produces Prostodin, Cerviprime, Primiprost, Partocin and many more.,Oncology-Company manufactures products such as Zoladex & Arimidex, Nolvadex and Iressa & Casodex under oncology segment,Infection-Company develops products such as Meronem and Vancocin CP and many more&Pain Control and Anaesthesia- Company offers products such as Xylocaine and Sensorcaine.The company plans to continue to invest in all focussed brands and on business development so as to increase sales and profitability and consequently increase stakeholder value..The company also engagged in the business of Healthcare.

COMPANY INFORMATION

  • Registered Office

  • Registrars

  • Management

    • Name

      Designation

    • Narayan K Seshadri

      Chairman & Ind.Director

    • Gagandeep Singh Bedi

      Managing Director

    • Rajesh Marwaha

      Executive Director

    • Ian John Parish

      Non Executive Director

    • Weiying Sarah Wang

      Non Executive Director

  • Listing

    Whether The Company Forms A Part Of The Following Indices -
    • Sensex

      No

    • Nifty

      No

    • Bse-100

      No

    • Bse-200

      No

    • S&P CNX 500

      Yes

    • CNX Midcap

      No

About AstraZeneca Pharma Ltd.

AstraZeneca is in the Pharmaceuticals sector.

It is listed on the BSE with a BSE Code of 506820 and the NSE with an NSE Code of ASTRAZEN.

Related Searches